Deciphera's Vimseltinib Study Evaluates Interaction with Oral Contraceptives
A clinical trial is underway to assess how vimseltinib affects the pharmacokinetics of a combined oral contraceptive.
Asset / Drug
Drug and asset intelligence for Vimseltinib with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.